CGMP - 6
Production Process Controls
Responsibilities from the beginning of production to consumer consumption
Production Process Control Definition
Production Process Control is a discipline that deals with architectures,
mechanisms and algorithms for maintaining the output of a specific process
within a desired range
which for Grifols means…
Each employee trains, understands and follows the guidance provided
through the CFR, EU Guidelines and Standard Operating Procedures to
ensure quality medications reach our customer.
2
What Procedures Are Followed And Where Is The
Guidance Derived??
Grifols has written procedures, known as Standard Operating Procedures (SOP), that are followed
for every task.
Guidance is derived from the Code of Federal Regulations and EU Guidelines along with state and
local guidelines.
There are also guidelines to follow in case of any deviation from procedure.
We have a quality control unit to ensure we follow the procedures and document any deviations.
Remember…Compliance is created as a team.
All Grifols team members are expected to perform at the highest level of excellence everyday, every
task, everytime.
3
SOP’s are our “rules” governing how we function as a
plasma center. Without SOP’s, centers would have no
direction and no guidelines to follow.
SOP’s are created so we can provide safety for our
donors and the people who receive the medications
we make. In many instances, SOP’s also ensure the
safety of our staff.
Our SOP’s are required to comply with CFR
standards.
SOP’s must be established, maintained, and followed
for all steps in the collection, processing, testing,
storage, and distribution of plasma and plasma
derived products.
STANDARD OPERATING PROCEDURES
Criteria to determine donor eligibility, including
acceptable medical history criteria
Methods for performing calibrations including the
requirement to have a range of minimum and
maximum values when determining acceptability
Any solution used to prepare the phlebotomy site
must give maximum assurance of sterility
CFR Requires the following be included in our Standard
Operating Procedures
Presentation Title | Presenter’s Name | Date | BUSINESS USE ONLY
Procedures to investigate any
donor adverse reactions
Storage temperatures and
methods for controlling storage
temperatures
Quality control procedures for
supplies and reagents
Schedules and procedures for
equipment maintenance and
calibration
Labeling procedures, including
ways to avoid labeling mix-ups
CFR Requires the following be included in our Standard
Operating Procedures
The CFR defines plasma and gives criteria for eligibility of donors
Processing of plasma if regulated in the CFR and gives specifics on the final outcome
• Plasma shall be stored in a container that has no color added to the plastic and shall be transparent so as to
allow for visual inspection of the contents
• The collection container shall be sealed and maintain closure to prevent contamination of the contents
• The container material shall not interact with the contents as to have an adverse affect on the safety, purity,
potency, and effectiveness of the product
• Prior to filling the collection container, it should be identified by the donor number
• The final product should be inspected for any abnormalities in color or physical appearance
• No preservatives can be added to the final product
• Each center shall establish and maintain procedures to ensure that mix-ups, damage, contamination, or other
adverse effects do not occur during handling.
OTHER CFR SPECIFICATIONS FOR PLASMA CENTERS
• Blood containers and softgoods must be pyrogen-free, sterile, and identified by a lot
number
• Each unit of blood and plasma must be identified by a number so as to directly relate
to the donor
• A sample of blood must be drawn from each donor on the day of the initial physical
examination and at least every 4 months thereafter; a serological test for syphilis, a
serum protein determination and a serum protein electrophoresis (SPE) shall be
performed on the sample
• A repeat donor who does not return at the time the 4-month sample is due, may be
plasmapheresed the day he returns, provided that no longer than 6 months has
elapsed; the sample shall be collect on the day of the donor’s return
• A repeat donor from whom a sample has not been obtained for a total period
exceeding 6 months shall be processed as a new donor
• The sample must be reviewed within 14 calendar days after it is drawn to determine
whether or not the donor should be deferred from further donations.
• If a determination is not made within 14 calendar days, the donor must be deferred
pending determination.
• If the protein levels are not within normal limits established by the testing laboratory,
the donor may not be reinstated from a deferral until the his protein values are at an
acceptable level and approved by the responsible physician.
WHAT ARE THE CFR SOURCE SPECIFICS FOR PLASMA?
GENERAL REQUIREMENTS CONTINUED…
• A donor identification system shall be established that identifies
the donor accurately to his records and laboratory data
• This system shall include a photograph of each donor and the
photograph shall be used on each visit to confirm the donor’s
identity
• The plasma shall be separated from the red blood cells
immediately after collection
• The maximum amount of red blood cells shall be returned to
the donor before another unit is collected
• Plasma collection shall not occur less than 2 days apart or
more frequently than twice in a 7-day period
General Requirements Continued
• Inspection of Source Plasma shall be checked for evidence of thawing
• Samples shall be marked so as to directly relate them to the donor
• Samples should be filled at the time the final product is prepared and by the
same person
• All samples shall be collected in a manner that does not contaminate the
contents of the final container
• Plasma centers must ensure donors has a record of being found eligible and
has a record of negative test results on two occasions in the past 6 months
Records
• Documentation shall be available to ensure shipping temperature requirements
are being met
• For each donor, we must maintain records including a separate and complete
record of initial and periodic examinations, tests, laboratory data, etc.
• The original copy of the donor’s consent for participation in plasmapheresis
must be kept
• Medical history and physical examination records showing eligibility must be
documented
• If a donor has a reaction, the record’s shall contain a full explanation of
measures taken to assist the donor and the outcome of the incident
Unsure what info to use from 610.1 subpart A to 610.61 subpart G ????
HELP….
13
Overview of Responsibilities
• Training
• Documentation
• Deviations
• Cleaning and Quality Controls
• Processing, Storing, Shipping Units and Samples
• Product Testing
• Fractionation
• Customer consumption
• Impact
Your Responsibility Starts…?
On your first day and then everyday thereafter...
•Training is the foundation of Quality.
•Each employee is responsible for owning their training.
•Whether it is initial, cross or developmental training, do not
sign for training you do not understand.
•Don’t just accept the how to perform a task…understand why.
•Once you sign for training…you will be responsible for your
performance.
•Always make the right decision…if you make a mistake
remember… integrity first…admit the mistake and work with
your team toward corrective actions.
14
Documentation
If it’s not documented it didn’t happen! In plasma it’s a reality!!!
Documentation is maintained for each donor for each step in the
plasmapheresis process. This includes:
•The original copy of the donor’s consent for participation in plasmapheresis.
•All suitability determinations are documented to include physicals, suitability testing,
plasmapheresis process, unit handling, storage, shipping and fractionation.
•Supply receipt, storage temperature, and room monitoring.
•Unit processing, storage and shipping information
•Testing of units
• Fractionation process
• From beginning to end…documentation shows every step for every unit
15
Deviations
Deviation Tracking System (DTS) is used to document any deviations from
Standard Operating Procedures.
•The team will identify deviations on the Deviation Tracking Log
located in each area.
•Each deviation requires a review, investigation (using open-ended
questions), discovery of root cause and a corrective action.
•Review of the deviation must include a process review as well as
performance review.
•To ensure compliance, an efficacy check must be completed to
ensure long term procedural/behavioral changes
•Managing this system includes identifying trends early, identifying
cause and implementing corrective actions.
16
Cleaning and Quality Controls
• Equipment must be maintained in a clean and orderly manner to ensure removal of
biohazard and chances for cross contamination.
• Cleanliness is for you, the donor and the consumer…it only takes and few minutes to
protect many people…take cleanliness seriously
• Equipment must be standardized and calibrated on a regular scheduled basis
following applicable SOP’s and operator’s manuals.
• Quality Control (QC) process must be reviewed and approved by Quality daily.
• If there is a deviation during the QC process, Quality may stop the use of certain
equipment and/or stop production.
• Should any piece of equipment not meet QC requirements, follow SOP requirements,
and if needed take the equipment out of service. Do not risk a donor’s life by using
equipment that does not meet standards.
17
Processing, Storing, Shipping Units and Samples
ATTENTION TO DETAIL IS KEY!
Check and double check labels to ensure all
• Units and samples must be segregated during processing to ensure there is no mix up of labels
and no cross contamination.
• Ensure the correct labels are placed on sample tubes to ensure correct identification for testing.
• To reduce protein break down, ensure all temperatures are maintained per SOP during storage
and shipment of units and samples.
• Pack units and samples properly to minimize the potential for damage during the shipping
process.
18
Customer Consumption
• Every day, thousands of people are impacted by the
medicine we produce. We owe it to these patients to
safely and effectively produce life saving plasma.
• Many patients count on you and your integrity every
day…do not let them down.
• Know that at any given day it could be any member of
your family receiving the medications produced from
your center…give that some thought
19
Impact
Customers lives depend on you everyday.
Each task you perform is integrity-based so remember:
Integrity is measured by the decisions you make when no one else is looking
Perform Each Task
Right the First Time Every Time Every Day
20
21
211SubpartE,F,H,K
600.13
606.6
606SubpartH
610
640SubpartD,G,H
EU
GuidelinesChapter1,56
640SubpartI,
J,
820SubpartG,H,I
RESOURCES
22
23
THANK YOU!

More Related Content

PPT
Quality assurance in blood banking
PPT
Production Process Control 10282016
PDF
Laboratory accreditation by iso 15189
PPTX
Quality assurance, quality control, good laboratory practice
PPTX
Strategies of assuring quality of laboratory results
PPTX
Quality control laboratory.
PDF
Good Laboratory Practices by Dr. A. Amsavel
PDF
Iso 15189 medical lab_ accred
Quality assurance in blood banking
Production Process Control 10282016
Laboratory accreditation by iso 15189
Quality assurance, quality control, good laboratory practice
Strategies of assuring quality of laboratory results
Quality control laboratory.
Good Laboratory Practices by Dr. A. Amsavel
Iso 15189 medical lab_ accred

What's hot (20)

PPTX
Qc lab 112070804001
PPT
Good Laboratory Practices (http://www.ubio.in)
PPTX
good laboratory practices
PPTX
Understand guidelines for documentation, collecting documentation, types of r...
PDF
GLP in Pharmaceutical Industry by Dr.A S Charan
PPT
Equipment reagent and materials in glp
PPTX
Glp guidelines in_qc_laboratory_as_per_ich
PPT
Quality control in the medical laboratory
PPTX
Understanding and implementing quality management system in medical laboratories
PPTX
PPTX
F sterility failure
PPTX
GLP (Good Laboratory Practices)
PPTX
Good laboratory practice
PPT
GLP in Bioequivalence Studies
PPTX
Out of specification (oos)1
PPT
Good laboratory practices
PPTX
Lec05 glp 2007
PPTX
PPT ON GOOD LABORATORY PRACTICES (GLP)
Qc lab 112070804001
Good Laboratory Practices (http://www.ubio.in)
good laboratory practices
Understand guidelines for documentation, collecting documentation, types of r...
GLP in Pharmaceutical Industry by Dr.A S Charan
Equipment reagent and materials in glp
Glp guidelines in_qc_laboratory_as_per_ich
Quality control in the medical laboratory
Understanding and implementing quality management system in medical laboratories
F sterility failure
GLP (Good Laboratory Practices)
Good laboratory practice
GLP in Bioequivalence Studies
Out of specification (oos)1
Good laboratory practices
Lec05 glp 2007
PPT ON GOOD LABORATORY PRACTICES (GLP)
Ad

Viewers also liked (17)

DOCX
TC Duties Revised
PPT
cGMP 4 Validation 1
PDF
FUNDIÇÃO
PDF
Mechanical Designer
PPTX
INCIDENT ANGLE & DBR
DOCX
M.A.Zakout Resume_11_5_2015
PPTX
Guest room
PDF
Tools, not only for Oracle RAC
PPTX
Adultoooo expooo
PPT
VALIDATION10282016
PPT
SONY Case Study
PDF
Oracle Globalization Support, NLS_LENGTH_SEMANTICS, Unicode
PDF
Oracle 12c Multi Process Multi Threaded
PPTX
Case study of dell
PPT
Feb Safety Slides
PPT
Buried Alive
TC Duties Revised
cGMP 4 Validation 1
FUNDIÇÃO
Mechanical Designer
INCIDENT ANGLE & DBR
M.A.Zakout Resume_11_5_2015
Guest room
Tools, not only for Oracle RAC
Adultoooo expooo
VALIDATION10282016
SONY Case Study
Oracle Globalization Support, NLS_LENGTH_SEMANTICS, Unicode
Oracle 12c Multi Process Multi Threaded
Case study of dell
Feb Safety Slides
Buried Alive
Ad

Similar to CGMP 6 - Production Process Control 2 (20)

PDF
fda-presentation_2015-ask-the-fdablood.pdf
DOCX
Phụ lục 4. Nguyên tắc GMP WHO trong sản xuất chế phẩm máu
PPTX
Schedule f
PDF
PPTX
QUALITY-CONTROL.pptx
PPTX
Blood Transfusion, Blood Products, and Safety.pptx
PDF
Recommendations for the production, control & regulation of human plasma for ...
PDF
Tp l3-402 nursing admin checklist 5 1 (1)
PPT
Plasma fractionation
PPTX
Plasma Fractionation Master.pptx
PPT
GTPs vs. cGMPs
PPTX
Blood bank
PPTX
Blood transfusions ppt
PPTX
Schedule F: Part XII B of Drugs & Cosmetics Rule
PPTX
Assessment & Development Of Palestinian Blood Bank System
PPTX
Blood transfusions
PDF
Taller Banco de Sangre - Seleccion donantes
PPTX
Donor Selection for blood donation voluntarily
PPT
Safe blood transfusion practices and policy of hospital
PPTX
APHERESIS [Autosaved].pptx apheresis ppt for mlt
fda-presentation_2015-ask-the-fdablood.pdf
Phụ lục 4. Nguyên tắc GMP WHO trong sản xuất chế phẩm máu
Schedule f
QUALITY-CONTROL.pptx
Blood Transfusion, Blood Products, and Safety.pptx
Recommendations for the production, control & regulation of human plasma for ...
Tp l3-402 nursing admin checklist 5 1 (1)
Plasma fractionation
Plasma Fractionation Master.pptx
GTPs vs. cGMPs
Blood bank
Blood transfusions ppt
Schedule F: Part XII B of Drugs & Cosmetics Rule
Assessment & Development Of Palestinian Blood Bank System
Blood transfusions
Taller Banco de Sangre - Seleccion donantes
Donor Selection for blood donation voluntarily
Safe blood transfusion practices and policy of hospital
APHERESIS [Autosaved].pptx apheresis ppt for mlt

CGMP 6 - Production Process Control 2

  • 1. CGMP - 6 Production Process Controls Responsibilities from the beginning of production to consumer consumption
  • 2. Production Process Control Definition Production Process Control is a discipline that deals with architectures, mechanisms and algorithms for maintaining the output of a specific process within a desired range which for Grifols means… Each employee trains, understands and follows the guidance provided through the CFR, EU Guidelines and Standard Operating Procedures to ensure quality medications reach our customer. 2
  • 3. What Procedures Are Followed And Where Is The Guidance Derived?? Grifols has written procedures, known as Standard Operating Procedures (SOP), that are followed for every task. Guidance is derived from the Code of Federal Regulations and EU Guidelines along with state and local guidelines. There are also guidelines to follow in case of any deviation from procedure. We have a quality control unit to ensure we follow the procedures and document any deviations. Remember…Compliance is created as a team. All Grifols team members are expected to perform at the highest level of excellence everyday, every task, everytime. 3
  • 4. SOP’s are our “rules” governing how we function as a plasma center. Without SOP’s, centers would have no direction and no guidelines to follow. SOP’s are created so we can provide safety for our donors and the people who receive the medications we make. In many instances, SOP’s also ensure the safety of our staff. Our SOP’s are required to comply with CFR standards. SOP’s must be established, maintained, and followed for all steps in the collection, processing, testing, storage, and distribution of plasma and plasma derived products. STANDARD OPERATING PROCEDURES
  • 5. Criteria to determine donor eligibility, including acceptable medical history criteria Methods for performing calibrations including the requirement to have a range of minimum and maximum values when determining acceptability Any solution used to prepare the phlebotomy site must give maximum assurance of sterility CFR Requires the following be included in our Standard Operating Procedures
  • 6. Presentation Title | Presenter’s Name | Date | BUSINESS USE ONLY Procedures to investigate any donor adverse reactions Storage temperatures and methods for controlling storage temperatures Quality control procedures for supplies and reagents Schedules and procedures for equipment maintenance and calibration Labeling procedures, including ways to avoid labeling mix-ups CFR Requires the following be included in our Standard Operating Procedures
  • 7. The CFR defines plasma and gives criteria for eligibility of donors Processing of plasma if regulated in the CFR and gives specifics on the final outcome • Plasma shall be stored in a container that has no color added to the plastic and shall be transparent so as to allow for visual inspection of the contents • The collection container shall be sealed and maintain closure to prevent contamination of the contents • The container material shall not interact with the contents as to have an adverse affect on the safety, purity, potency, and effectiveness of the product • Prior to filling the collection container, it should be identified by the donor number • The final product should be inspected for any abnormalities in color or physical appearance • No preservatives can be added to the final product • Each center shall establish and maintain procedures to ensure that mix-ups, damage, contamination, or other adverse effects do not occur during handling. OTHER CFR SPECIFICATIONS FOR PLASMA CENTERS
  • 8. • Blood containers and softgoods must be pyrogen-free, sterile, and identified by a lot number • Each unit of blood and plasma must be identified by a number so as to directly relate to the donor • A sample of blood must be drawn from each donor on the day of the initial physical examination and at least every 4 months thereafter; a serological test for syphilis, a serum protein determination and a serum protein electrophoresis (SPE) shall be performed on the sample • A repeat donor who does not return at the time the 4-month sample is due, may be plasmapheresed the day he returns, provided that no longer than 6 months has elapsed; the sample shall be collect on the day of the donor’s return • A repeat donor from whom a sample has not been obtained for a total period exceeding 6 months shall be processed as a new donor • The sample must be reviewed within 14 calendar days after it is drawn to determine whether or not the donor should be deferred from further donations. • If a determination is not made within 14 calendar days, the donor must be deferred pending determination. • If the protein levels are not within normal limits established by the testing laboratory, the donor may not be reinstated from a deferral until the his protein values are at an acceptable level and approved by the responsible physician. WHAT ARE THE CFR SOURCE SPECIFICS FOR PLASMA?
  • 9. GENERAL REQUIREMENTS CONTINUED… • A donor identification system shall be established that identifies the donor accurately to his records and laboratory data • This system shall include a photograph of each donor and the photograph shall be used on each visit to confirm the donor’s identity • The plasma shall be separated from the red blood cells immediately after collection • The maximum amount of red blood cells shall be returned to the donor before another unit is collected • Plasma collection shall not occur less than 2 days apart or more frequently than twice in a 7-day period
  • 10. General Requirements Continued • Inspection of Source Plasma shall be checked for evidence of thawing • Samples shall be marked so as to directly relate them to the donor • Samples should be filled at the time the final product is prepared and by the same person • All samples shall be collected in a manner that does not contaminate the contents of the final container • Plasma centers must ensure donors has a record of being found eligible and has a record of negative test results on two occasions in the past 6 months
  • 11. Records • Documentation shall be available to ensure shipping temperature requirements are being met • For each donor, we must maintain records including a separate and complete record of initial and periodic examinations, tests, laboratory data, etc. • The original copy of the donor’s consent for participation in plasmapheresis must be kept • Medical history and physical examination records showing eligibility must be documented • If a donor has a reaction, the record’s shall contain a full explanation of measures taken to assist the donor and the outcome of the incident
  • 12. Unsure what info to use from 610.1 subpart A to 610.61 subpart G ???? HELP….
  • 13. 13 Overview of Responsibilities • Training • Documentation • Deviations • Cleaning and Quality Controls • Processing, Storing, Shipping Units and Samples • Product Testing • Fractionation • Customer consumption • Impact
  • 14. Your Responsibility Starts…? On your first day and then everyday thereafter... •Training is the foundation of Quality. •Each employee is responsible for owning their training. •Whether it is initial, cross or developmental training, do not sign for training you do not understand. •Don’t just accept the how to perform a task…understand why. •Once you sign for training…you will be responsible for your performance. •Always make the right decision…if you make a mistake remember… integrity first…admit the mistake and work with your team toward corrective actions. 14
  • 15. Documentation If it’s not documented it didn’t happen! In plasma it’s a reality!!! Documentation is maintained for each donor for each step in the plasmapheresis process. This includes: •The original copy of the donor’s consent for participation in plasmapheresis. •All suitability determinations are documented to include physicals, suitability testing, plasmapheresis process, unit handling, storage, shipping and fractionation. •Supply receipt, storage temperature, and room monitoring. •Unit processing, storage and shipping information •Testing of units • Fractionation process • From beginning to end…documentation shows every step for every unit 15
  • 16. Deviations Deviation Tracking System (DTS) is used to document any deviations from Standard Operating Procedures. •The team will identify deviations on the Deviation Tracking Log located in each area. •Each deviation requires a review, investigation (using open-ended questions), discovery of root cause and a corrective action. •Review of the deviation must include a process review as well as performance review. •To ensure compliance, an efficacy check must be completed to ensure long term procedural/behavioral changes •Managing this system includes identifying trends early, identifying cause and implementing corrective actions. 16
  • 17. Cleaning and Quality Controls • Equipment must be maintained in a clean and orderly manner to ensure removal of biohazard and chances for cross contamination. • Cleanliness is for you, the donor and the consumer…it only takes and few minutes to protect many people…take cleanliness seriously • Equipment must be standardized and calibrated on a regular scheduled basis following applicable SOP’s and operator’s manuals. • Quality Control (QC) process must be reviewed and approved by Quality daily. • If there is a deviation during the QC process, Quality may stop the use of certain equipment and/or stop production. • Should any piece of equipment not meet QC requirements, follow SOP requirements, and if needed take the equipment out of service. Do not risk a donor’s life by using equipment that does not meet standards. 17
  • 18. Processing, Storing, Shipping Units and Samples ATTENTION TO DETAIL IS KEY! Check and double check labels to ensure all • Units and samples must be segregated during processing to ensure there is no mix up of labels and no cross contamination. • Ensure the correct labels are placed on sample tubes to ensure correct identification for testing. • To reduce protein break down, ensure all temperatures are maintained per SOP during storage and shipment of units and samples. • Pack units and samples properly to minimize the potential for damage during the shipping process. 18
  • 19. Customer Consumption • Every day, thousands of people are impacted by the medicine we produce. We owe it to these patients to safely and effectively produce life saving plasma. • Many patients count on you and your integrity every day…do not let them down. • Know that at any given day it could be any member of your family receiving the medications produced from your center…give that some thought 19
  • 20. Impact Customers lives depend on you everyday. Each task you perform is integrity-based so remember: Integrity is measured by the decisions you make when no one else is looking Perform Each Task Right the First Time Every Time Every Day 20
  • 22. 22